Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19
2024 · New England Journal of Medicine · 120 citations
https://doi.org/10.1056/nejmoa2309003
J
Jesus Abraham Simón Campos
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
1.3K
Citations
15
h-index
18
i10-index
Jesus Abraham Simón Campos is an academic researcher from Autonomous University of Yucatán. The author has contributed to research in topics: COVID-19 Clinical Research Studies & SARS-CoV-2 and COVID-19 Research & Rheumatoid Arthritis Research and Therapies. The author has an h-index of 15, co-authored 47 publications.
ORCID: 0000-0001-9630-7792Papers by this author
worksA Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
2023 · New England Journal of Medicine · 112 citations
https://doi.org/10.1056/nejmoa2209856
Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trial
2015 · Arthritis Research & Therapy · 54 citations
https://doi.org/10.1186/s13075-015-0612-7
Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A Phase 3 Randomized Trial
2024 · Clinical Infectious Diseases · 10 citations
https://doi.org/10.1093/cid/ciae551
Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial
2023 · Infectious Diseases and Therapy · 7 citations
https://doi.org/10.1007/s40121-023-00861-7
Safety, Efficacy and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Treatment of Mild-to-Moderate COVID-19: 15-Month Final Analysis of the TACKLE Trial
2024 · Infectious Diseases and Therapy · 4 citations
https://doi.org/10.1007/s40121-024-00931-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat